Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial-Reference-Cited by-同舟云学术

Methods paper: Performance characteristics of novel assays for circulating levels of proglucagon-derived peptides and validation in a placebo controlled cross-over randomized clinical trial

Published:2022-04 Issue: Volume:129 Page:155157
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Perakakis Nikolaos,Kalra Bhanu,Angelidi Angeliki M.,Kumar Ajay,Gavrieli Anna,Yannakoulia Mary,Mantzoros Christos S.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference39 articles.

1. Hamster preproglucagon contains the sequence of glucagon and two related peptides;Bell;Nature,1983

2. Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease;Sandoval;Physiol Rev,2015

3. Glucagon-like peptide 1 (GLP-1);Muller;Mol Metab,2019

4. The Role of Glicentin and Oxyntomodulin in Human Metabolism: New Evidence and New Directions;Perakakis;J Clin Endocrinol Metab,2020

5. Circulating levels of gastrointestinal hormones in response to the most common types of bariatric surgery and predictive value for weight loss over one year: evidence from two independent trials;Perakakis;Metabolism: clinical and experimental,2019

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response to lowering plasma glucose is characterised by decreased oxyntomodulin: Results from a randomised controlled trial;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-06

2. Bariatric surgery, through beneficial effects on underlying mechanisms, improves cardiorenal and liver metabolic risk over an average of ten years of observation: A longitudinal and a case-control study;Metabolism;2024-03

3. Post-prandial secretion of glucagon-like peptide-2 (GLP-2) after carbohydrate-, fat- or protein enriched meals in healthy subjects;Peptides;2023-11

4. Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals;Clinical Nutrition;2023-08

5. Circulating levels of proglucagon‐derived peptides are differentially regulated by the glucagon‐like peptide‐1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6‐month long interventional study;Diabetes, Obesity and Metabolism;2023-05-29